As a secreted proteoglycan, SRGN plays a pivotal role in invasive metastasis and immune escape in several cancers, including non‐small‐cell lung cancer (NSCLC), breast cancer, and OSCC.13, 40, 41. Here, SRGN is linked to breast cancer.